Cargando…

The Benefit of Thrombectomy in Patients With Low ASPECTS Is a Matter of Shades of Gray—What Current Trials May Have Missed

Randomized trials supporting the benefit of endovascular treatment in acute ischemic stroke patients with a large early infarction are not yet available. Few retrospective studies exist that suggest a potential positive treatment effect on functional outcome, as well as procedural safety. However, p...

Descripción completa

Detalles Bibliográficos
Autores principales: Broocks, Gabriel, Meyer, Lukas, McDonough, Rosalie, Bechstein, Matthias, Hanning, Uta, Fiehler, Jens, Kemmling, Andre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795604/
https://www.ncbi.nlm.nih.gov/pubmed/35095708
http://dx.doi.org/10.3389/fneur.2021.718046
_version_ 1784641105739907072
author Broocks, Gabriel
Meyer, Lukas
McDonough, Rosalie
Bechstein, Matthias
Hanning, Uta
Fiehler, Jens
Kemmling, Andre
author_facet Broocks, Gabriel
Meyer, Lukas
McDonough, Rosalie
Bechstein, Matthias
Hanning, Uta
Fiehler, Jens
Kemmling, Andre
author_sort Broocks, Gabriel
collection PubMed
description Randomized trials supporting the benefit of endovascular treatment in acute ischemic stroke patients with a large early infarction are not yet available. Few retrospective studies exist that suggest a potential positive treatment effect on functional outcome, as well as procedural safety. However, potential benefit or harm of MT in patients with low initial ASPECTS is still a subject of current debate, and in particular, how to select these patients for treatment. The purpose of this pilot study was to evaluate how early tissue water uptake in acute ischemic brain might determine lesion fate and functional outcome in low ASPECTS patients undergoing MT. We observed that the degree of early water uptake measured by quantitative NWU was significantly associated with functional outcome in low ASPECTS patients, yielding a higher diagnostic power compared to other parameters such as ASPECTS, age, or NIHSS. No conclusive evidence of a beneficial effect of successful reperfusion was observed in patients with low ASPECTS and high NWU, which highlights the potential of NWU as a tool to specify patient selection.
format Online
Article
Text
id pubmed-8795604
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87956042022-01-29 The Benefit of Thrombectomy in Patients With Low ASPECTS Is a Matter of Shades of Gray—What Current Trials May Have Missed Broocks, Gabriel Meyer, Lukas McDonough, Rosalie Bechstein, Matthias Hanning, Uta Fiehler, Jens Kemmling, Andre Front Neurol Neurology Randomized trials supporting the benefit of endovascular treatment in acute ischemic stroke patients with a large early infarction are not yet available. Few retrospective studies exist that suggest a potential positive treatment effect on functional outcome, as well as procedural safety. However, potential benefit or harm of MT in patients with low initial ASPECTS is still a subject of current debate, and in particular, how to select these patients for treatment. The purpose of this pilot study was to evaluate how early tissue water uptake in acute ischemic brain might determine lesion fate and functional outcome in low ASPECTS patients undergoing MT. We observed that the degree of early water uptake measured by quantitative NWU was significantly associated with functional outcome in low ASPECTS patients, yielding a higher diagnostic power compared to other parameters such as ASPECTS, age, or NIHSS. No conclusive evidence of a beneficial effect of successful reperfusion was observed in patients with low ASPECTS and high NWU, which highlights the potential of NWU as a tool to specify patient selection. Frontiers Media S.A. 2022-01-14 /pmc/articles/PMC8795604/ /pubmed/35095708 http://dx.doi.org/10.3389/fneur.2021.718046 Text en Copyright © 2022 Broocks, Meyer, McDonough, Bechstein, Hanning, Fiehler, Kemmling https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Broocks, Gabriel
Meyer, Lukas
McDonough, Rosalie
Bechstein, Matthias
Hanning, Uta
Fiehler, Jens
Kemmling, Andre
The Benefit of Thrombectomy in Patients With Low ASPECTS Is a Matter of Shades of Gray—What Current Trials May Have Missed
title The Benefit of Thrombectomy in Patients With Low ASPECTS Is a Matter of Shades of Gray—What Current Trials May Have Missed
title_full The Benefit of Thrombectomy in Patients With Low ASPECTS Is a Matter of Shades of Gray—What Current Trials May Have Missed
title_fullStr The Benefit of Thrombectomy in Patients With Low ASPECTS Is a Matter of Shades of Gray—What Current Trials May Have Missed
title_full_unstemmed The Benefit of Thrombectomy in Patients With Low ASPECTS Is a Matter of Shades of Gray—What Current Trials May Have Missed
title_short The Benefit of Thrombectomy in Patients With Low ASPECTS Is a Matter of Shades of Gray—What Current Trials May Have Missed
title_sort benefit of thrombectomy in patients with low aspects is a matter of shades of gray—what current trials may have missed
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795604/
https://www.ncbi.nlm.nih.gov/pubmed/35095708
http://dx.doi.org/10.3389/fneur.2021.718046
work_keys_str_mv AT broocksgabriel thebenefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed
AT meyerlukas thebenefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed
AT mcdonoughrosalie thebenefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed
AT bechsteinmatthias thebenefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed
AT hanninguta thebenefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed
AT fiehlerjens thebenefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed
AT kemmlingandre thebenefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed
AT broocksgabriel benefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed
AT meyerlukas benefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed
AT mcdonoughrosalie benefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed
AT bechsteinmatthias benefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed
AT hanninguta benefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed
AT fiehlerjens benefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed
AT kemmlingandre benefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed